Get started
Author

Mark D. Long

Observed names: D Long, Mark, Long, Mark, Long, Mark D., M. D. Long, Mark D Long, Mark Long
ORCID: 0000-0003-1120-8176
Observed ORCID: 0000-0003-1120-8176
OpenAlex ID: A5028515700
Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas
2018 · S. R. Rosario, M. D. Long, et al. · Nature Communications · 268
PDF
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
2020 · Yota Yasumizu, Hasan Rajabi, et al. · Nature Communications · 166
PDF
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s
2020 · Takaaki Oba, Mark D. Long, et al. · Nature Communications · 137
PDF
Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model
2021 · Johannes Gebert, Ozkan Gelincik, et al. · Gastroenterology · 118
PDF
The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer
2017 · Mark Long, Dominic Smiraglia, et al. · Biomolecules · 108
PDF
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation
2021 · Yixuan Zhou, Ingmar Niels Bastian, et al. · Proceedings of the National Academy of Sciences · 101
PDF
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
2019 · Song Liu, Junko Matsuzaki, et al. · Journal for ImmunoTherapy of Cancer · 85
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
2021 · Nami Yamashita, Mark Long, et al. · Journal for ImmunoTherapy of Cancer · 83
PDF
MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells
2020 · Masayuki Hagiwara, Yota Yasumizu, et al. · Cancer Research · 78
MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells
2021 · Masayuki Hagiwara, Atsushi Fushimi, et al. · Oncogene · 72
PDF
Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy
2020 · Hayley C. Affronti, Aryn M. Rowsam, et al. · Nature Communications · 67
PDF
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells
2019 · Tsuyoshi Hata, Hasan Rajabi, et al. · Cancer Research · 66
MUC1-C drives stemness in progression of colitis to colorectal cancer
2020 · Wei Li, Ning Zhang, et al. · JCI Insight · 62
PDF
The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression
2018 · Mark D. Long, Prashant K. Singh, et al. · Oncogene · 60
PDF
Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients
2014 · Prashant K. Singh, Leah Preus, et al. · Oncotarget · 58
PDF
Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma
2018 · Anna Bianchi-Smiraglia, Archis Bagati, et al. · Journal of Clinical Investigation · 56
PDF
Pan-Cancer Analyses of the Nuclear Receptor Superfamily
2015 · Mark D. Long, Moray J. Campbell · Nuclear Receptor Research · 55
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer
2024 · Sheng-Yu Ku, Yanqing Wang, et al. · Journal of Clinical Investigation · 49
Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling
2022 · Kenichi Makino, Mark D Long, et al. · Journal for ImmunoTherapy of Cancer · 47
CD8 + T cell immunity blocks the metastasis of carcinogen-exposed breast cancer
2021 · Kaiwen Li, Tiancheng Li, et al. · Science Advances · 45
Vitamin D Receptor and RXR in the Post‐Genomic Era
2014 · Mark D. Long, Lara E. Sucheston‐Campbell, et al. · Journal of Cellular Physiology · 43
Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes
2017 · Prashant K. Singh, Patrick R. van den Berg, et al. · BMC Genomics · 41
PDF
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer
2024 · Spencer R. Rosario, Mark D. Long, et al. · Nature Communications · 39
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer
2022 · Nami Yamashita, Yoshihiro Morimoto, et al. · Molecular Cancer Research · 38
Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability
2020 · Yuanquan Yang, Rohit K Jain, et al. · Journal for ImmunoTherapy of Cancer · 38
PDF
Works count: 450
Citation count: 2,657
H-index: 26
I10-index: 55
Year
Topic
Type